Literature DB >> 359746

Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

W Gerhard, R G Webster.   

Abstract

Antigenic variants of A/PR/8/34 [HON1] influenza virus were selected after a single passage of the parent virus in embryonated chicken eggs in the presence of monoclonal antibodies to this virus. The monoclonal antibodies were produced by a hybridoma and were specific for an antigenic determinant on the HA molecule of the parent virus. Seven antigenic variants were analyzed with 95 monoclonal anti-HA antibodies prepared in vitro in the splenic fragment culture system. Three subgroups of antigenic variants were distinguished. The antigenic changes were primarily recognized by monoclonal antibodies to the strain- specific determinants of the parental hemagglutinin (HA) molecule. Monoclonal antibodies to HA determinants shared (in an identical or cross-reactive form) by parental virus and more than three heterologous viruses of the HON1 and H1N1 subtypes were unable to recognize the antigenic change on the variants. Similarly, heterogeneous antibody preparations could not differentiate between parental and variant viruses. The results are compatible with the idea that the HA of PR8 has available a large repertoire of antigenic modifications that may result from single amino acid substitutions, and that antigenic changes can occur in the strain- specific determinants on the HA molecule in the absence of concomitant changes in the cross-reactive HA determinants. The findings suggest that antigenic drift, in order to be epidemiologically significant, probably requires a series of amino acid substitutions in, or close to, the antigenic area on the HA molecule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359746      PMCID: PMC2184934          DOI: 10.1084/jem.148.2.383

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1.

Authors:  A ISAACS; A W GLEDHILL; C H ANDREWES
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

2.  A new avian influenza virus from feral birds in the USSR: recombination in nature?

Authors:  R G Webster; V A Isachenko; M Carter
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody.

Authors:  J D Rosenthal; K Hayashi; A L Notkins
Journal:  Appl Microbiol       Date:  1973-04

4.  Binding of antibodies to isolated haemagglutinin and neuraminidase molecules of influenza virus observed in the electron microscope.

Authors:  N G Wrigley; W G Laver; J C Downie
Journal:  J Mol Biol       Date:  1977-01-25       Impact factor: 5.469

5.  Antigenic variants of influenza A virus obtained in vitro.

Authors:  L R Haaheim; G C Schild
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

6.  Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells.

Authors:  H Koprowski; W Gerhard; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

7.  The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.

Authors:  W Gerhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

8.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

9.  Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.

Authors:  P GERBER; D HAMRE; C G LOOSLI
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

10.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory.

Authors:  J L Virelizier; R Postlethwaite; G C Schild; A C Allison
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  55 in total

1.  Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.

Authors:  G Spira; R R Pollock; A Bargellesi; M D Scharff
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

2.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region.

Authors:  J W Yewdell; A Taylor; A Yellen; A Caton; W Gerhard; T Bächi
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

5.  Hyper-antigenic variation occurs with human rhinovirus type 17.

Authors:  L J Patterson; V V Hamparian
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.

Authors:  M I Muggeridge; V J Isola; R A Byrn; T J Tucker; A C Minson; J C Glorioso; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.

Authors:  A Natali; P F Panizzi; C Chezzi; J S Oxford
Journal:  J Hyg (Lond)       Date:  1984-04

8.  Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo.

Authors:  L Lefrancois
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

9.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?

Authors:  Yong Chong; Hideyuki Ikematsu
Journal:  Hum Vaccin Immunother       Date:  2017-10-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.